Learn
Medical EducationEvidence-Based MedicinePatient Education
ICU Toolkit
CalculatorsProtocols & CardsICU Setup
CPT & BillingZad TalkForumContact
Home / Calculators / EUROMACS-RHF Risk Score Calculator

EUROMACS-RHF Risk Score Calculator

Estimates the risk of early severe right heart failure after continuous-flow left ventricular assist device (LVAD) implantation from five preoperative variables.

EUROMACS-RHF Score
Fill in the fields above to see the result.

How to read the result

ScoreRiskEarly severe RHF, derivationValidation
0-2Low11.0%12.5%
2.5-4Intermediate25.7%27.8%
4.5-9.5High43.1%42.4%

Early severe right heart failure meant, within 30 days, short- or long-term right-sided mechanical support, continuous inotropes for 14 days or more, or inhaled nitric oxide for 48 hours or more. Patients who developed it had lower 1-year survival (53% vs 71%) and a median ICU stay of 24 days rather than 7.

Scoring

VariablePoints
INTERMACS profile 1-32
Multiple intravenous inotropes (3 or more)2.5
Severe RV dysfunction on echo (visual grade)2
RA pressure / PCWP above 0.542
Hemoglobin 10 g/dL (100 g/L) or lower1

INTERMACS profiles 1-3 are critical cardiogenic shock, progressive decline despite inotropes, and stable but dependent on inotropes or temporary support after failed weaning. In the derivation registry, multiple inotropes meant 3 or more intravenous inotropes before surgery. The paper also gives a postoperative version that adds cardiopulmonary bypass time above 100 minutes; this calculator uses the preoperative score.

Validation

Derived and validated in the EUROMACS registry: 2,988 adults receiving a HeartMate II, HeartWare HVAD or HeartMate 3, randomly split into derivation (2,000) and validation (988) cohorts. Right heart failure occurred in 21.7%, and the c-index was 0.70 in derivation and 0.67 in validation, better than earlier scores. In an external cohort of 662 patients at three US centers (2007-2017), right heart failure occurred in 32% and the AUC was 0.64; high-risk patients had higher in-hospital and 2-year mortality, and the authors judged its clinical utility still to be determined.

References

  1. Soliman OII, Akin S, Muslem R, et al. Derivation and validation of a novel right-sided heart failure model after implantation of continuous flow left ventricular assist devices: the EUROMACS (European Registry for Patients with Mechanical Circulatory Support) right-sided heart failure risk score. Circulation. 2018;137(9):891-906. PMID 28847897
  2. Rivas-Lasarte M, Kumar S, Derbala MH, et al. Prediction of right heart failure after left ventricular assist implantation: external validation of the EUROMACS right-sided heart failure risk score. Eur Heart J Acute Cardiovasc Care. 2021;10(7):723-732. PMID 34050652
  3. Stevenson LW, Pagani FD, Young JB, et al. INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant. 2009;28(6):535-541. PMID 19481012
Keep reading

Related articles

All Cardiovascular →